NovImmune's Series B - III Round

NovImmune raised a round of funding on December 10, 2010. Investors include BZ Bank Aktiengesellschaft.

NovImmune is a biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.…

Articles about NovImmune's Series B - III Round: